News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Newman James W. Jr.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 05/25/2023 |
4
| Newman James W. Jr. (Director) has filed a Form 4 on ADIAL PHARMACEUTICALS, INC.|
Txns:
| Granted 50,000 options to buy
@ $0.3025, valued at
$15.1k
|
|
| 02/25/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/03/2022 |
4
| Newman James W. Jr. (Director) has filed a Form 4 on ADIAL PHARMACEUTICALS, INC.|
Txns:
| Bought 10,000 shares
@ $2.66, valued at
$26.6k
Bought 5,000 shares
@ $2.72, valued at
$13.6k
Bought 10,000 shares
@ $2.71, valued at
$27.1k
|
|
| 11/30/2021 |
4
| Newman James W. Jr. (Director) has filed a Form 4 on ADIAL PHARMACEUTICALS, INC.|
Txns:
| Bought 10,000 shares
@ $2.85, valued at
$28.5k
|
|
| 02/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/28/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/30/2020 |
4
| Newman James W. Jr. (Director) has filed a Form 4 on ADIAL PHARMACEUTICALS, INC.|
Txns:
| Bought 5,000 shares
@ $1.42, valued at
$7.1k
Bought 10,000 shares
@ $1.34, valued at
$13.4k
Bought 4,644 shares
@ $1.35, valued at
$6.3k
|
|
| 03/05/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/14/2018 |
SC 13D
| Newman James W. Jr. reports a 9.8% stake in ADIAL PHARMACEUTICALS, INC. |
| 11/13/2018 |
4
| Newman James W. Jr. (Director) has filed a Form 4 on ADIAL PHARMACEUTICALS, INC.|
Txns:
| Disposed of 20,000 options to buy
@ $5, valued at
$100k
Acquired 20,000 options to buy
@ $5, valued at
$100k
Acquired 20,000 options to buy
@ $6.25, valued at
$125k
Disposed of 92,000 options to buy
@ $5, valued at
$460k
Acquired 92,000 options to buy
@ $5, valued at
$460k
Acquired 92,000 options to buy
@ $6.25, valued at
$575k
|
|
| 08/02/2018 |
4
| Newman James W. Jr. (Director) has filed a Form 4 on ADIAL PHARMACEUTICALS, INC.|
Txns:
| Converted 29,931 shares
@ $0
Converted 21,715 shares
@ $0
Converted 5,178 shares
@ $0
Acquired 20,000 shares
@ $0
Acquired 92,000 shares
@ $0
Bought 10,000 shares
@ $0
Bought 10,000 shares
@ $0
Converted 29,931 convertible notes
@ $0.44, valued at
$13.2k
Converted 21,715 convertible notes
@ $0.44, valued at
$9.6k
Converted 5,178 convertible notes
@ $0.44, valued at
$2.3k
Acquired 29,931 options to buy
@ $6.25, valued at
$187.1k
|
|
| 07/26/2018 |
3
| Newman James W. Jr. (Director) has filed a Form 3 on ADIAL PHARMACEUTICALS, INC. |
|
|